Sedegah M - Search Results

1

Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.

Sedegah M, Rogers WO, Belmonte M, Belmonte A, Banania G, Patterson NB, Rusalov D, Ferrari M, Richie TL, Doolan DL. Sedegah M, et al. Vaccine. 2010 Apr 9;28(17):3055-65. doi: 10.1016/j.vaccine.2009.10.044. Epub 2009 Oct 30. Vaccine. 2010. PMID: 19879998

2

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.

Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghten RA, Beaudoin RL, Smith D, Hoffman SL. Sedegah M, et al. Vaccine. 1992;10(9):578-84. doi: 10.1016/0264-410x(92)90436-n. Vaccine. 1992. PMID: 1323900

3

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL. Khusmith S, et al. Among authors: sedegah m. Science. 1991 May 3;252(5006):715-8. doi: 10.1126/science.1827210. Science. 1991. PMID: 1827210

4

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

Charoenvit Y, Mellouk S, Sedegah M, Toyoshima T, Leef MF, De la Vega P, Beaudoin RL, Aikawa M, Fallarme V, Hoffman SL. Charoenvit Y, et al. Among authors: sedegah m. Exp Parasitol. 1995 May;80(3):419-29. doi: 10.1006/expr.1995.1054. Exp Parasitol. 1995. PMID: 7729477

5

Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.

Wang HH, Rogers WO, Kang YH, Sedegah M, Hoffman SL. Wang HH, et al. Among authors: sedegah m. Mol Biochem Parasitol. 1995 Feb;69(2):139-48. doi: 10.1016/0166-6851(94)00159-k. Mol Biochem Parasitol. 1995. PMID: 7770079

6

Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine.

Hoffman SL, Sedegah M, Hedstrom RC. Hoffman SL, et al. Among authors: sedegah m. Vaccine. 1994 Dec;12(16):1529-33. doi: 10.1016/0264-410x(94)90078-7. Vaccine. 1994. PMID: 7879419

7

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Sedegah M, et al. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9866-70. doi: 10.1073/pnas.91.21.9866. Proc Natl Acad Sci U S A. 1994. PMID: 7937907 Free PMC article.

8

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant.

Hoffman SL, Edelman R, Bryan JP, Schneider I, Davis J, Sedegah M, Gordon D, Church P, Gross M, Silverman C, et al. Hoffman SL, et al. Among authors: sedegah m. Am J Trop Med Hyg. 1994 Nov;51(5):603-12. doi: 10.4269/ajtmh.1994.51.603. Am J Trop Med Hyg. 1994. PMID: 7985753 Clinical Trial.

9

Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

Khusmith S, Sedegah M, Hoffman SL. Khusmith S, et al. Among authors: sedegah m. Infect Immun. 1994 Jul;62(7):2979-83. doi: 10.1128/iai.62.7.2979-2983.1994. Infect Immun. 1994. PMID: 8005684 Free PMC article.

10

Nucleic acid malaria vaccines. Current status and potential.

Hoffman SL, Doolan DL, Sedegah M, Gramzinski R, Wang H, Gowda K, Hobart P, Margalith M, Norman J, Hedstrom RC. Hoffman SL, et al. Among authors: sedegah m. Ann N Y Acad Sci. 1995 Nov 27;772:88-94. doi: 10.1111/j.1749-6632.1995.tb44734.x. Ann N Y Acad Sci. 1995. PMID: 8546416 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters